Skip to main content
MedEdPublish logoLink to MedEdPublish
. 2021 Feb 22;10:51. [Version 1] doi: 10.15694/mep.2021.000051.1

The challenge of comorbidities: should we focus on clinical decision support as much as medical education?

Kieran Walsh 1,a
PMCID: PMC10939611  PMID: 38486607

Abstract

This article was migrated. The article was marked as recommended.

Comorbidities present a great challenge to healthcare professionals and the health service. One in four patients now have two or more conditions. The prevalence of comorbidities increases with age and the population is continuing to grow older. Our response thus far has been slow and the solutions that have been suggested may not be scalable. There have been multiple calls for medical education to do more to address the issue of comorbidities. However existing ways of tackling this problem are unlikely to be scalable. It is impossible to learn and remember how to manage the many different potential combinations of acute diseases and comorbidities. Online clinical decision support has until the present enabled the management of patients with single conditions. But advances in clinical decision support can now enable the management of patients with multiple conditions.

Keywords: Comorbidities, clinical decision support, medical education

Clinical decision support for comorbidities

Comorbidities present a great challenge to healthcare professionals and the health service. One in four patients now have two or more conditions ( Barnett et al., 2012). The prevalence of comorbidities increases with age and the population is continuing to grow older. Importantly comorbidities are also associated with socioeconomic deprivation ( Barnett et al., 2012). And socioeconomically deprivation increases the likelihood that patients will develop comorbidities younger in life ( Whitty et al., 2020). Mental health disorders are also associated with increased numbers of comorbid conditions ( Barnett et al., 2012). Remarkably one in three emergency patients admitted to hospital in the UK have five or more conditions ( Steventon et al., 2018). Patients with comorbidities spend longer in hospital and this increased length of stay is associated with increased costs ( Steventon et al., 2018). The challenge of comorbidities has traditionally been seen as a problem for high income countries, but the problem is now increasing in middle income countries also ( Whitty et al., 2020). Comorbidities represent a problem for health systems - and also for individual patients. There are multiple examples. Just one example is that of COPD and type 2 diabetes - both very common conditions. Up to twenty percent of patients with COPD also have type 2 diabetes ( Parappil et al., 2010). Yet the treatment for one condition can make the other one worse - for example steroids for exacerbations of COPD can cause hyperglycemia. At a patient, professional and population level, comorbidities present a massive challenge to the health service.

Our response thus far has been slow and the solutions that have been suggested may not be scalable. There have been multiple calls for medical education to do more to address the issue of comorbidities ( Whitty et al., 2020). Whitty et al. have written that “training from medical school onwards, clinical teams, and clinical guidelines, however, all tend to be organised along single disease or single organ lines.” ( Whitty et al., 2020). The authors call for the “management of coexisting physical and mental health problems” to be “embedded into medical training and continuous professional development, including for specialists.” ( Whitty et al., 2020). There are multiple recommendations on how to educate healthcare professionals in the management of patients with comorbidities. Guidance from the National Institute for Health and Care Excellence (NICE) in the UK contains generic suggestions that would be relevant to all patients with comorbidities. These include “knowing the patient as an individual, tailoring healthcare services for each patient, continuity of care and relationships, and enabling patients to actively participate in their care.” ( Nice, 2016) It suggests communication and team working skills that will enable this to happen. It also advises that healthcare professionals should: “after a discussion of disease and treatment burden and the person’s, personal goals, values and priorities, develop and agree an individualised management plan with the person.” ( Nice, 2016)

This is helpful - but only up to a point. Communication skills and team working skills are important for patients with multiple illnesses. And the patient should be seen as the most important member of the team. However these skills are equally important in the management of patients with single conditions. And a definite shortcoming is that generic skills will not give the healthcare professional everything that they need to know to answer the patient’s questions. Ultimately a patient with the common combination of COPD and diabetes will want to know what the best way is to treat these conditions. Their doctor will need to be able to tell them. And they will need to be confident that they are giving an evidence-based answer and that their recommendations for the treatment of one condition will not make the other condition worse. They will also need to be reassured that treatment for one condition will not lead to other conditions being neglected or overlooked.

There are few resources that can help with this. There are occasional educational articles that outline how to manage a patient with more than one illness ( Stamp and Chapman, 2013; Neder et al., 2018). But these are hard to find and harder to quality assure. In any case, this approach is not scalable - simply due the exponential number of potential combinations of comorbidities. For example a patient with COPD might have diabetes, or hypertension, or diabetes and hypertension. This is a common scenario - with very many patients in hospital having very many comorbidities ( Steventon et al., 2018). Even looking up just two different guidelines is impossible in the acute setting - the shortest guidelines are at least several pages long. There is no time for busy healthcare professionals to do this. It is certainly impossible to learn and remember how to manage the many different potential combinations of acute diseases and comorbidities.

It is tempting to think that artificial intelligence might have the answer. It might have an answer in the future but currently there are many barriers. These include the unintended consequences of artificial intelligence, its complete dependence on data (which is not always reliable), and the potential of artificial intelligence to discriminate against certain groups of patients or learners ( Walsh, 2020). This last issue is especially important in the context of patients with comorbidities - who often come from socially deprived sections of the population.

Thus artificial intelligence is unlikely to be the solution to this problem - as least not yet. But technology must be part of the solution - even if it does not involve machine learning but rather straightforward rule-based systems.

Online clinical decision support has until now enabled the management of patients with single conditions. But advances in clinical decision support can now enable the management of patients with multiple conditions.

The Comorbidities tool from BMJ Best Practice is built on functionality that enables healthcare professionals to add one or more comorbidities to an existing management plan and thus receive a holistic management plan. It has recently been launched and is in the process of being further developed and rolled out. It is relevant as a point of care clinical decision support tool but also as an educational tool. The reason is that healthcare professionals who use a comorbidities based clinical decision support tool are learning as they practice medicine. The reason why they use the tool is because they need to know something and thus have a learning need. They then engage in a sixty second bite of micro learning - a short but effective episode of learning. Finally they put their learning into action for the benefit of their patients. The whole process takes minutes, but it is based on sound educational principles - those of needs assessment, learning and putting learning into practice. If done properly with due attention to reflection on thoughts, actions and feelings all put into context, it is essentially self-regulated learning in action ( White, Gruppen and Fantone, 2014).

Context is vitally important and, in today’s world, multiple overlapping and complex comorbidities are now part of the contextualised norm. This new world has been brought into stark relief by the Covid-19 pandemic. Espinosa and colleagues conducted a meta-analysis of comorbidities in patients with Covid-19 ( Espinosa et al., 2020). They found that 42% of patients with Covid-19 had comorbidities; 61% of those admitted to the Intensive Care Unit had comorbidities; and 77% of those who died had comorbidities. Hypertension was the most prevalent comorbidity (affecting 32% of patients). Other common comorbidities included diabetes (22%), heart disease (13%), and COPD (8%). It is patients with comorbidities who are becoming seriously ill.

Tackling the issue of comorbidities will be essential in managing the Covid-19 pandemic. But comorbidities will remain a challenge for health services far into the future. Medical education that is focussed on comorbidities will help. But it won’t be enough on its own. Advanced forms of clinical decision support will be essential to the better management of patients with multiple illnesses.

Take Home Messages

  • Comorbidities present a great challenge to healthcare professionals and the health service.

  • There have been multiple calls for medical education to do more to address the issue of comorbidities.

  • Existing ways of tackling this problem are unlikely to be scalable.

  • Advances in clinical decision support can now enable the management of patients with multiple conditions.

Notes On Contributors

Dr Kieran Walsh is Clinical Director at BMJ. He is the clinical lead of the medical education and clinical decision support resources at BMJ. He has a vast amount of experience in online medical education, clinical decision support, face to face delivery of medical education, and summative and formative assessment.

Declarations

The author has declared the conflicts of interest below.

Kieran Walsh works for BMJ which produces a range of resources in medical education and clinical decision support.

Ethics Statement

This is a personal view and not research.

External Funding

This article has not had any External Funding

[version 1; peer review: This article was migrated, the article was marked as recommended]

Bibliography/References

  1. Barnett K., Mercer S. W., Norbury M., Watt G., et al. (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 380(9836), pp.37–43. 10.1016/S0140-6736(12)60240-2 [DOI] [PubMed] [Google Scholar]
  2. Espinosa O. A., Zanetti A. D. S., Antunes E. F., Longhi, et al. (2020) Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Revista do Instituto de Medicina Tropical de São Paulo. 62. 10.1590/S1678-9946202062043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Neder J. A., Rocha A., Alencar M. C. N., Arbex F., et al. (2018) Current challenges in managing comorbid heart failure and COPD. Expert Review of Cardiovascular Therapy. 16(9), pp.653–673. 10.1080/14779072.2018.1510319 [DOI] [PubMed] [Google Scholar]
  4. NICE. (2016) Multimorbidity: clinical assessment and management NICE guideline. NICE. Available at: https://www.nice.org.uk/guidance/ng56( Accessed: 18 September 2020). [Google Scholar]
  5. Parappil A. Depczynski B. Collett P. and Marks G. B., (2010) Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 15(6), pp.918–922. 10.1111/j.1440-1843.2010.01781.x [DOI] [PubMed] [Google Scholar]
  6. Stamp L. K. and Chapman P. T.(2013) Gout and its comorbidities: implications for therapy. Rheumatology. 52(1), pp.34–44. 10.1093/rheumatology/kes211 [DOI] [PubMed] [Google Scholar]
  7. Steventon A., Deeny S., Friebel R., Gardner T., et al. (2018) Briefing: emergency hospital admissions in England: which may be avoidable and how? The Health Foundation. Available at: https://www.health.org.uk/sites/default/files/Briefing_Emergency%20admissions_web_final.pdf( Accessed: 20 September 2020). [Google Scholar]
  8. Walsh K.(2020) Artificial intelligence and healthcare professional education: superhuman resources for health? Postgrad Med J. 96(1133), pp.121–122. 10.1136/postgradmedj-2019-137132 [DOI] [PubMed] [Google Scholar]
  9. White C. B. Gruppen L. D. and Fantone J. C.(2014) Self-regulated learning in medical education.in Swanwick T.(ed) Understanding medical education. Wiley-Blackwell, Sussex, pp.271–282. [Google Scholar]
  10. Whitty C. J., MacEwen C., Goddard A., Alderson D., et al. (2020) Rising to the challenge of multimorbidity. BMJ. 6(368), p.6964. 10.1136/bmj.l6964 [DOI] [PMC free article] [PubMed] [Google Scholar]
MedEdPublish (2016). 2021 Mar 6. doi: 10.21956/mep.18884.r26956

Reviewer response for version 1

Megan Anakin 1

This review has been migrated. The reviewer awarded 2 stars out of 5 The topic of comorbidities caught my eye because it is an important area in health professions education. This opinion piece focuses on arguing that decision support software may be useful in managing complexity and that educators should consider how we use it in medical education. My comments are intended to assist the author to extend this brief article and enhance the argument presented with further description and details. Please consider revising the title because the implied comparison between decision support and medical education does not clearly express that the comparison presented is about current methods used to teach and learn about managing comorbidities and a new method described in the article. The claim that learning to manage comorbidities is “impossible” is an absolute statement, therefore, it needs a supporting reference, otherwise it should be rephrased with ‘hedging’ language to show that that in education there are always choices. Further explanation should be provided to explain why “Our response thus far has been slow and the solutions that have been suggested may not be scalable” and “Thus artificial intelligence is unlikely to be the solution to this problem – as least not yet”. More than one example is needed to support the claim that “There are multiple recommendations on how to educate healthcare professionals in the management of patients with comorbidities”.References are needed to support the factual claims made in the paragraph in the ‘Clinical decision support for comorbidities’. Please consider combining the last two paragraphs of the article so the relevance of managing comorbidities in the COVID19 era is more strongly connected to the need to provide enhance our teach and learn methods about managing comorbidities. Please consider revising the sentence: “But it won’t be enough on its own” to remove the contraction and specify the subject to make the sentence more formal and complete.I would be very happy to read and review a revised version of this article.

Reviewer Expertise:

NA

No decision status is available

MedEdPublish (2016). 2021 Feb 25. doi: 10.21956/mep.18884.r26958

Reviewer response for version 1

Balakrishnan Nair 1

This review has been migrated. The reviewer awarded 5 stars out of 5 This is a timely article. With the increasing ageing of the population, co-morbidities are on the rise. It is associated with polypharmacy. With the growing specialisation and single organ doctors , patients see too many specialists who do not communicate with each other leading to frustrated and confused patients. We had looked at the PBL cases in medical schools and most of the cases are single organ problems which are sorted in a very short time frame, a far cry from real life. We have evidence-based medicine for single diseases; what we need is Medicine -based evidence. So if we need to prepare our future doctors , we need to teach them about co-morbidities and how to care for their patients

Reviewer Expertise:

NA

No decision status is available

MedEdPublish (2016). 2021 Feb 23. doi: 10.21956/mep.18884.r26957

Reviewer response for version 1

BALAJI ARUMUGAM 1

This review has been migrated. The reviewer awarded 5 stars out of 5 Dear Dr Kieran Walsh is Clinical Director at BMJ,Thank you so much for your personal opinion article which is the most needed for all the medical practitioners globally to focus more on comorbidities in decision making for the treatment aspect of their own specialty. TO My PERSONAL OPINION Unfortunately, the overspecialization, compartmentalization of the mindset of the medical practitioners in managing the patients than treating them as a whole individual is becoming a problem for the patient as well as the treating specialist at some point of time. Due to co morbid illnesses - Patient side issues1. Increase in Number of visits 2. increase in number of drugs consumed (Often overlapped/overdose)3. Drug interactions and side effects4. Money and time spent The big solution would be as of now - Common Co morbid tool training in clinical general practice from the level of undergraduate itself with more comprehensive approach in postgraduate training in medical education to sensitize the medical professionals.

Reviewer Expertise:

NA

No decision status is available


Articles from MedEdPublish are provided here courtesy of Association for Medical Education in Europe

RESOURCES